Nav: ₹ 42.529 ↑ 0.81%
[as on 1 October, 2025]
Nav chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Mirae Asset Healthcare Fund Direct Growth | -3.16% | 0.81% | 0.81% | -0.13% | 0.12% | -1.31% | 22.01% | 18.54% | 21.76% | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.59% |
0.01% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.41% |
Equity
| Name | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.92% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 8.15% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 6.79% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | 6.32% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 6.30% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 6.02% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | 4.94% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 4.27% |
| Fortis Healthcare Ltd. | Healthcare Services | 3.89% |
| Krishna Institute of Medical Sciences Ltd. | Healthcare Services | 3.82% |
| IPCA Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.44% |
| Aster DM Healthcare Ltd. | Healthcare Services | 3.33% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 3.27% |
| JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.77% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.75% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.70% |
| Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | 2.50% |
| Eris Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 2.36% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 2.30% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | 2.22% |
| Wockhardt Ltd. | Pharmaceuticals & Biotechnology | 1.74% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.62% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.57% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | 1.54% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | 0.93% |
| Sagility India Ltd. | IT - Services | 0.83% |
| Deepak Nitrite Ltd. | Chemicals & Petrochemicals | 0.79% |
| Neogen Chemicals Ltd. | Chemicals & Petrochemicals | 0.52% |
| Syngene International Ltd. | Healthcare Services | 0.51% |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | 0.50% |
Debt
| Name | Rating | Weight % |
|---|
| Mirae Asset Liquid Fund-Direct Plan-Growth | | 0.01% |
Portfolio data is as on date 31 August, 2025
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 42.529 as on 1 October, 2025.
What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are -3.16% as on 1 October, 2025.
What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are -1.31% as on 1 October, 2025.
What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 22.01% as on 1 October, 2025.
What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 18.54% as on 1 October, 2025.
